Investigational 21-Valent Pneumococcal Conjugate Vaccine Immunogenic, Safe
Merck’s investigational 21-valent pneumococcal conjugate vaccine, V116, elicited positive immune responses in vaccine-naïve and previously vaccinated individuals, according to results
Read More